InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: JPG77 post# 36624

Saturday, 11/14/2015 1:44:36 PM

Saturday, November 14, 2015 1:44:36 PM

Post# of 461833
Yes correct....
1-the deal with Dr. V was done at a time before the knowledge and interest in Sigma 1 receptor agonist recearch was any where near what it is today...and;
2- Dr. V gets a 6% royalty from profits.

Now do not think this is insignificant, if you are a doctor that believes in the science and is mainly interested in seeing your molecule advanced through trials, a royalty is better than up front cash... First of all, the margins for this drug will be huge... maybe 90% ish...and so even though the royalty is on profits it will still be a huge royalty....maybe equal to 4% of revenue!!!!!
Second, with the size of the AD, and dementia markets, what could this work out to for Dr. V. In my best case estimation, if it is SOC and 4X better than the current SOC, do the numbers..whats 4% of 20 Billion rev worth?...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News